Yoshiko Hashii
Overview
Explore the profile of Yoshiko Hashii including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
867
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kato M, Okamoto Y, Imamura T, Kada A, Saito A, Iijima-Yamashita Y, et al.
J Clin Oncol
. 2024 Nov;
43(5):567-577.
PMID: 39531610
Purpose: The JCCG ALL-B12 clinical trial aimed to evaluate the effectiveness of unvalidated treatment phases for pediatric ALL and develop a safety-focused treatment framework. Patients And Methods: Patients age 1-19...
2.
Hashii Y, Kawaguchi K, Kurakami H, Umeda K, Hasegawa D, Taki T, et al.
Transplant Cell Ther
. 2024 Aug;
30(11):1102.e1-1102.e12.
PMID: 39181536
The AML-05 study aimed to examine the efficacy and safety of a therapeutic strategy based on risk stratification for low-, intermediate-, or high-risk acute myeloid leukemia (AML) pediatric patients. Allogeneic...
3.
Sakaguchi H, Taga T, Ishida H, Hama A, Okamoto Y, Sano H, et al.
Bone Marrow Transplant
. 2024 Aug;
59(11):1621-1624.
PMID: 39174743
No abstract available.
4.
Yagi T, Kukita Y, Matsuoka H, Wakamatsu T, Tamiya H, Watanabe M, et al.
Intern Med
. 2024 Jul;
64(5):791-796.
PMID: 39048371
Inflammatory myofibroblastic tumors (IMTs) are rare sarcomas composed of myofibroblastic and fibroblastic cells, accompanied by inflammatory cell infiltration. Many IMTs exhibit clonal rearrangement of anaplastic lymphoma kinase (ALK). We herein...
5.
Ishida H, Imamura T, Kobayashi R, Hashii Y, Deguchi T, Miyamura T, et al.
Cancer Med
. 2024 Jun;
13(12):e7246.
PMID: 38888368
Background: Asparaginase is essential for treating T-cell acute lymphoblastic leukemia (T-ALL). Despite the ongoing debate on whether T-ALL and T-cell lymphoblastic lymphoma (T-LBL) are the same disease entity or two...
6.
Kurosawa S, Fukuda T, Ichinohe T, Hashii Y, Kanda J, Goto H, et al.
Cytotherapy
. 2024 May;
26(10):1185-1192.
PMID: 38804991
This nationwide study retrospectively examined the center effect on allogeneic hematopoietic stem cell transplantation (allo-HSCT) for adult B-cell acute lymphoblastic leukemia. The cohort analyses were separated into Philadelphia chromosome (Ph)-positive...
7.
Yagi T, Suzuki O, Matsuoka H, Shinyashiki K, Wakamatsu T, Tamiya H, et al.
Radiol Case Rep
. 2024 Apr;
19(7):2674-2678.
PMID: 38645952
fusion sarcoma is a type of round-cell sarcoma with fusion that was newly categorized in the 2020 World Health Organization classification of soft tissue and bone tumors. In general, local...
8.
Kudo H, Nakata K, Morishima T, Kato M, Kuwabara Y, Sawada A, et al.
Int J Cancer
. 2024 Apr;
155(5):839-848.
PMID: 38608173
Although the survival rate of patients with childhood cancer has greatly improved, long-term survivors face specific problems such as the late effects of cancer treatment. In this study, we estimated...
9.
Konuma T, Uchida N, Takeda W, Doki N, Yoshihara S, Nishida T, et al.
Vox Sang
. 2024 Mar;
119(6):612-618.
PMID: 38425018
Background And Objectives: ABO blood group mismatch between the donor and the recipient can affect the success of the transplant as well as problems with the red blood cells during...
10.
Yanada M, Yano S, Kuwatsuka Y, Kawamura K, Fukuda T, Ichinohe T, et al.
Bone Marrow Transplant
. 2024 Feb;
59(4):541-549.
PMID: 38321271
This study aimed to address the prognostic impact of center experience based on the data of 7821 adults with acute myeloid leukemia who underwent allogeneic hematopoietic cell transplantation (HCT) from...